跳至主要内容
临床试验/NCT02298504
NCT02298504进行中(未招募)4 期

Evaluation of MTA Pulpotomy, Biodentine Pulpotomy, and Glass Ionomer Indirect Pulp Treatment in Primary Teeth

University of Maryland, Baltimore1 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2018年7月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
76
试验地点
1
主要终点
Clinical success after pulpotomy

研究概览

简要总结

In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.

详细描述

Pediatric patients having deep decay in primary molars seen at UMMC, UMSOD, and University of Maryland Rehabilitation and Orthopaedic Institute, will be included in the sample. Teeth with deep caries, >50% into dentin, will be randomly assigned using a table of random numbers to the three treatment groups:

Group 1 pulpotomy with MTA, Group 2 pulpotomy with Biodentine, Group 3 indirect pulp treatment. Treatment will be performed by board certified pediatric dentists or they will directly supervise pediatric dental residents at each site as part of their regular protocol for treating deep caries.

Radiographs will be taken as prescribed in the Guideline for taking Radiographs in Children by the American Academy of Pediatric Dentistry.

Twice yearly clinical examinations will be performed by the treating dentists or pediatric dental residents to check for any soft tissue pathology such as abscess or mobility of treated tooth/teeth. If treatment success/failure consensus between the blinded dentists is not reached, a third dentist will be consulted.

The success/failure data will be entered onto spreadsheets and examined statistically using statistical software.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
2 Years 至 9 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients with deep dental decay in primary molars
  • Teeth with signs and symptoms of reversible pulpitis

排除标准

  • Teeth with clinical symptoms of irriversible pulpitis or pulp necrosis or acute dental infection
  • Children with systemic illness that contraindicated vital pulp treatment such a sickle cell disease
  • Teeth that are not restorable

研究组 & 干预措施

Indirect pulp cap

Experimental

IDP will be performed for this group

干预措施: Vitrebond (Device)

MTA pulpotomy

Experimental

MTA pulpotomy will be performed for this group

干预措施: Mineral Trioxide Aggregate (Drug)

Biodentin pulpotomy

Experimental

Biodentin pulpotomy will be performed for this group

干预措施: Biodentin (Drug)

结局指标

主要结局

Clinical success after pulpotomy

时间窗: 3 years

No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth

Clinical success after indirect pulp cap

时间窗: 3 years

No signs of abscess or any swelling related to the tooth, no signs of fistula or other pathology, no signs of pathologic mobility, no post-operative pain, no pain on palpation or percussion of the tooth

Radiographic success after pulpotomy

时间窗: 3 years

No signs of root resorption (internal or external), no signs of furcation involvement or periapical radiolucency, no signs of loss of lamina dura, presence of normal appearance of periodontal ligament space

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Vineet Dhar

Associate Professor, Graduate Program Director

University of Maryland, Baltimore

研究点 (1)

Loading locations...

相似试验